KKR to buy WebMD in whooping Rs 18,000 crore deal

Published On 2017-07-25 09:17 GMT   |   Update On 2017-07-25 09:17 GMT
Advertisement

Online health publisher WebMD Health Corp said it agreed to be bought by private equity firm KKR & Co in a deal valued at about 2.8 billion dollars (Rs 18000 crore).


The deal brings together WebMD's websites, such as WebMD.com, Medscape.com and MedicineNet.com, and those owned by KKR unit Internet Brands Inc, including DentalPlans.com and AllAboutCounseling.com.


KKR will pay 66.50 dollar per share, a premium of 20.5 percent to WebMD's Friday closing price. WebMD's shares were trading at $66 before the opening bell.

Advertisement

Reuters reported on Sunday that KKR was nearing a deal to buy the online health information provider.


Founded in 1996, WebMD has grown into one of the most popular health websites for consumers and medical professionals, attracting more than 70 million monthly unique visitors in 2016, according to analytics company comScore Inc.


WebMD also owns medical news and education brand Medscape, which accounted for around 60 percent of its advertising revenue in 2016.


The New York-based company said in February it would explore its options, after a slowdown in advertising paid for by pharmaceutical companies.


The deal, approved by the WebMD board, is expected to close in the fourth quarter of 2017.


J.P. Morgan Securities LLC is WebMD's financial adviser, while Shearman & Sterling LLP is its legal adviser.


Simpson Thacher & Bartlett LLP is Internet Brands' legal adviser.


(Reporting by Ankur Banerjee in Bengaluru; Editing by Saumyadeb Chakrabarty)

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News